Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma

Autor: Hurwitz, Michael E., Markowski, Paul, Yao, Xiaopan, Deshpande, Hari, Patel, Jaymin, Mortazavi, Amir, Donadio, Alessia, Stein, Mark N., Kelly, William Kevin, Petrylak, Daniel Peter, Mehnert, Janice M.
Zdroj: In Clinical Genitourinary Cancer December 2018 16(6):437-444
Databáze: ScienceDirect
Externí odkaz: